BioCentury
ARTICLE | Clinical News

APT070 genetically modified fragment of anti-CD35 antibody regulatory update

June 30, 2003 7:00 AM UTC

The FDA granted Orphan Drug designation to Adprotech's APT070 to prevent delayed graft function in solid organ transplantation. The product received Orphan Medicinal Product designation from the EU to...